151 related articles for article (PubMed ID: 10924497)
1. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.
Otsuka M; Kato N; Lan K; Yoshida H; Kato J; Goto T; Shiratori Y; Omata M
J Biol Chem; 2000 Nov; 275(44):34122-30. PubMed ID: 10924497
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
Ahn JY; Chung EY; Kwun HJ; Jang KL
Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity.
Ray RB; Steele R; Meyer K; Ray R
Gene; 1998 Feb; 208(2):331-6. PubMed ID: 9524287
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
Kwon JA; Rho HM
Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
[TBL] [Abstract][Full Text] [Related]
5. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
Lan KH; Sheu ML; Hwang SJ; Yen SH; Chen SY; Wu JC; Wang YJ; Kato N; Omata M; Chang FY; Lee SD
Oncogene; 2002 Jul; 21(31):4801-11. PubMed ID: 12101418
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.
Majumder M; Ghosh AK; Steele R; Ray R; Ray RB
J Virol; 2001 Feb; 75(3):1401-7. PubMed ID: 11152513
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.
Kwun HJ; Jung EY; Ahn JY; Lee MN; Jang KL
J Gen Virol; 2001 Sep; 82(Pt 9):2235-2241. PubMed ID: 11514734
[TBL] [Abstract][Full Text] [Related]
8. Activation of p53 tumor suppressor by hepatitis C virus core protein.
Lu W; Lo SY; Chen M; Wu Kj; Fung YK; Ou JH
Virology; 1999 Nov; 264(1):134-41. PubMed ID: 10544138
[TBL] [Abstract][Full Text] [Related]
9. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
Gong GZ; Jiang YF; He Y; Lai LY; Zhu YH; Su XS
World J Gastroenterol; 2004 Aug; 10(15):2223-7. PubMed ID: 15259070
[TBL] [Abstract][Full Text] [Related]
10. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
[TBL] [Abstract][Full Text] [Related]
11. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta.
Dubourdeau M; Miyamura T; Matsuura Y; Alric L; Pipy B; Rousseau D
J Hepatol; 2002 Oct; 37(4):486-92. PubMed ID: 12217602
[TBL] [Abstract][Full Text] [Related]
12. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines.
Siavoshian S; Abraham JD; Kieny MP; Schuster C
Arch Virol; 2004 Feb; 149(2):323-36. PubMed ID: 14745598
[TBL] [Abstract][Full Text] [Related]
13. The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation.
Jung EY; Lee MN; Yang HY; Yu D; Jang KL
Virus Res; 2001 Nov; 79(1-2):109-15. PubMed ID: 11551651
[TBL] [Abstract][Full Text] [Related]
14. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
15. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.
Kao CF; Chen SY; Chen JY; Wu Lee YH
Oncogene; 2004 Apr; 23(14):2472-83. PubMed ID: 14968111
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.
Florese RH; Nagano-Fujii M; Iwanaga Y; Hidajat R; Hotta H
Virus Res; 2002 Dec; 90(1-2):119-31. PubMed ID: 12457968
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interaction between HCV core protein and the different p73 isoforms.
Alisi A; Giambartolomei S; Cupelli F; Merlo P; Fontemaggi G; Spaziani A; Balsano C
Oncogene; 2003 May; 22(17):2573-80. PubMed ID: 12730672
[TBL] [Abstract][Full Text] [Related]
19. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
